Navigation Links
Edwards Lifesciences Announces Organizational Changes
Date:2/18/2008

IRVINE, Calif., Feb. 18 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW), a world leader in products and technologies to treat advanced cardiovascular disease, today announced the company's strengthened alignment into a business unit organizational structure, along with the planned departure in the middle of 2008 of corporate officers Anita B. Bessler, Stuart L. Foster, and Alex Martin.

"To support our growth strategy, we have recently made product portfolio changes and increased investment in our market-leading businesses. As a result, we can now further our evolution into customer-focused business units and simplify our organization," said Michael A. Mussallem, Edwards' chairman and CEO. "We express our sincere thanks and gratitude to Anita, Stu and Alex for their significant contributions to Edwards over the years. Consistent with our Credo, they have served as trusted partners with patients, employees, customers and shareholders to provide innovative solutions for people fighting cardiovascular disease."

Bessler, who joined the company in 1988 and led the growth of Edwards' heart valve business into its current position as the global market leader, will continue in an ongoing advisory role with Edwards.

Foster, who joined the company in 1994 and served as the company's technology leader and oversaw the development and growth of the critical care and vascular businesses, will also continue in an ongoing advisory role with Edwards.

Martin, who joined Edwards in 2004, plans to pursue other opportunities upon his departure. He oversaw the development and expansion of the company's North American sales and marketing organization, Edwards' largest operating region.

As a result of the operational integration announced today, corporate officers Donald E. Bobo, Jr., Paul C. Redmond, Carlyn D. Solomon, and Larry L. Wood will assume management of additional U.S. sales, marketing and operational functions within their business units, and will report directly to Mussallem. In addition, corporate officer Corinne H. Lyle will undertake additional global responsibilities.

About Edwards Lifesciences

Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, vascular disease and critical care technologies. The company's global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.


'/>"/>
SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Edwards Lifesciences to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
2. Edwards Lifesciences to Host Earnings Conference Call on February 5, 2008
3. Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve
4. Edwards Lifesciences Completes Acquisition of CardioVations Product Line
5. Edwards Lifesciences Forecasts Strong Growth in 2008
6. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
7. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
10. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
11. Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , ... January 18, 2017 , ... ... at the CHI SCOPE Summit for Clinical Ops Executives (Hyatt Regency Miami, January ... discussions to examine vital clinical research issues such as trial performance metrics, patient ...
(Date:1/18/2017)... 18, 2017 Shareholder rights law firm Johnson ... the board members of CoLucid Pharmaceuticals, Inc. (NASDAQ: ... with the proposed sale of the Company to Eli ... develops small molecules for the acute treatment of migraines. ... had signed a definitive merger agreement with Eli Lilly. ...
(Date:1/18/2017)... , Jan. 18, 2017  Market Research Future published a ... Market is expected to grow at a CAGR of 12% during ... ... caused due to the abnormal cell division without any control. These ... harm to them. These cancer cells can spread to other parts ...
(Date:1/17/2017)...  An international team of researchers from UC ... Hospital Albrechtsen Research Centre/University of Manitoba have identified ... need affecting nearly one in 15 Americans. Published ... results identify small molecule drugs with neuroprotective and ... in animal models of metabolic, chemical and infection ...
Breaking Biology Technology:
(Date:12/15/2016)... 15, 2016 ... Research and Markets has announced the addition of the ... The report forecasts the global military biometrics market to grow ... The report has been prepared based on an in-depth market analysis with ... growth prospects over the coming years. The report also includes a discussion ...
(Date:12/8/2016)... 2016 Market Research Future published a half cooked research ... Biometric Security and Service Market is expected to grow over the ... Market Highlights: ... Mobile Biometric Security and Service Market ... need of authentication and security from unwanted cyber threats. The increasing ...
(Date:12/7/2016)... , Dec. 7, 2016   Veridium , ... the appointment of new CEO James Stickland ... with decades of experience, has served in senior ... where he specialized in expanding a pipeline of ... portfolios. He most recently served as managing director ...
Breaking Biology News(10 mins):